Julie Johnson, Representative
sell disclosed on 14 May 2025 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Public company research profile
This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.
Company research history
Raymond James Financial, Inc. Common Stock (RJF)
Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.
4 disclosures
3 insiders
0 cluster signals
-3.9% avg. 30d outcome
Company facts
- Ticker / ISIN
- RJF / Not available
- Exchange
- Not available
- Country
- US
- Sector
- Not available
Disclosure history
Jared Moskowitz, Representative
sell disclosed on 21 Aug 2024 via House STOCK Act disclosures
- Transaction value
- US$100,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +7.4%
Daniel Goldman, Representative
sell disclosed on 17 Apr 2023 via House STOCK Act disclosures
- Transaction value
- US$15,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -8.9%
Daniel Goldman, Representative
buy disclosed on 24 Feb 2023 via House STOCK Act disclosures
- Transaction value
- US$15,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -14.1%